Showing results (1551-1560 of 1,625) with videos related to
Sort By:
Pageof 163
The Journal of Experimental Medicine|September 3, 2021
Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndromeJulien Stackowicz, Nicolas Gaudenzio, Nadine Serhan, et al.Molecular Systems Biology|March 12, 2026
Structure-function relationship of alpha-synuclein fibrillar polymorphs derived from distinct synucleinopathiesTetiana Serdiuk, Virginie Redeker, Jimmy Savistchenko, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 27, 2010
Accuracy to 2nd International HIV-1 RNA WHO Standard: assessment of three generations of quantitative HIV-1 RNA nucleic acid amplification testsJoachim Glaubitz, Dorothea Sizmann, Christian O Simon, et al.Nature Communications|April 23, 2016
Hallmarks of the Mott-metal crossover in the hole-doped pseudospin-1/2 Mott insulator Sr2IrO4Yue Cao, Qiang Wang, Justin A Waugh, et al.Cancer Gene Therapy|January 20, 2007
Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injectionJ C Solheim, A J Reber, A E Ashour, et al.Nature Communications|July 29, 2021
Mechanistic insights into the three steps of poly(ADP-ribosylation) reversalJohannes Gregor Matthias Rack, Qiang Liu, Valentina Zorzini, et al.Nature Communications|December 18, 2019
A unified form of low-energy nodal electronic interactions in hole-doped cuprate superconductorsT J Reber, X Zhou, N C Plumb, et al.Journal of Thrombosis and Haemostasis : JTH|January 20, 2006
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)S Miyakis, M D Lockshin, T Atsumi, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|October 22, 2014
Tunable trimers: using temperature and pressure to control luminescent emission in gold(I) pyrazolate-based trimersChristopher H Woodall, Sara Fuertes, Christine M Beavers, et al.The Journal of Clinical Investigation|November 27, 2019
The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptorsBianca Balbino, Pauline Herviou, Ophélie Godon, et al.Pageof 163